What we do

Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships

Our approach to science

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to help prevent serious infectious diseases.

Our proprietary protein vaccine platform and adjuvant technology can be applied to address current and emerging global health threats.

red jelly spheres

Recombinant nanoparticle vaccine technology

We are committed to delivering novel products that leverage cutting edge recombinant protein nanoparticles to protect against a broad range of infectious diseases.

Learn more
orange antigens image

Matrix-M™ adjuvant technology

Our saponin-based Matrix-M™ adjuvant enhances the immune response and has a dose-sparing effect, both of which are critical to successful vaccine development.

Learn more